The global psoriatic arthritis therapeutics drug market is expected to grow at a significant CAGR during the forecast period (2021-2027). Psoriatic arthritis is a form of arthritis that affects some people who have psoriasis, which is a condition that develops red patches on the skin with silvery scales. Most people develop psoriasis first and are later diagnosed with psoriatic arthritis. However, joint problems can sometimes begin before skin patches appear. This condition develops when the immune system begins to attack healthy cells and tissue. The abnormal immune response causes inflammation in the joints as well as overproduction of skin cells.

One of the major factors that can fuel the development of psoriatic arthritis is obesity. Hence, as the prevalence of obesity increases, the risk of psoriatic arthritis is expected to increase as well. Other factors like an unhealthy lifestyle with indulgence in alcohol and smoking can also be attributed as risk factors for the development of psoriatic arthritis. Moreover, the development of new therapeutic methods is also expected to drive the growth of this market.

The global psoriatic arthritis therapeutics drug market analysis includes some of the key market players such as Pfizer Inc., Eisai Inc., UCB Biosciences Inc., Sanofi S.A., Otsuka Pharmaceutical, Sumitomo Dainippon Pharma Co, and Johnson & Johnson, among others. To maintain a strong position in the market, these market players are adopting various strategic moves, such as product launches, partnerships, collaborations, and mergers and acquisitions. 

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape: NDPHARM, Wanhua Biochem, Jiangxi Haoran Bio-Pharma, Techpool, Microbic Biosystems Inc, and LIVZON among others. 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Psoriatic Arthritis Therapeutics Drug Market by Segment

By Drug

• Nonsteroidal anti-inflammatory drug (NSAID)

• Disease-modifying antirheumatic drug (DMARD)

• Biologic drug

• Enzyme inhibitor

By Disease Type

• Asymmetric Psoriatic Arthritis

• Symmetric Psoriatic Arthritis

• Distal Interphalangeal Predominant (Dip) Psoriatic Arthritis

• Spondylitis

• Arthritis Mutilans

Global Psoriatic Arthritis Therapeutics Drug Market by Region